-
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Source: Buzz FX / 04 Jan 2025 03:16:14 America/New_York
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Given Consensus Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat January 4, 2025 Share Link copied to clipboard. Shares of Viridian Therapeutics, Inc.
Read more...